2022
DOI: 10.31557/apjcp.2022.23.5.1529
|View full text |Cite
|
Sign up to set email alerts
|

Antiproliferative Activities of Lipophililic Fluoroquinolones- Based Scaffold Against a Panel of Solid and Liquid Cancer Cell Lines

Abstract: Objectives: In this work, 9 lipophilic-acid chelating FQs (fluoroquinolones) comprising chelating groups have been prepared, characterized and screened for in vitro cytotoxicity, radical scavenging and antiinflammation propensities. Methods: Using sulforhodamine B colorimetric bioassay vs. cisplatin; FQs-inflicted reductions' of viability against breast T47D and MCF7, Pancreatic PANC-1, colorectal HT29, HCT116, SW620, CACO2, SW480 and Leukaemia K562 cancer cell lines were examined in quadruplicates/dose/cell l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(21 citation statements)
references
References 22 publications
0
19
0
Order By: Relevance
“…These data were further validated with other cell lines including colorectal cancer (CRC); fortifying the fact that atorvastatin has an apoptotic effect on cancer cells, particularly colorectal (CRC) and BC (in SW620 cells with IC 50 value accounting to 0.0018 ±0000 µM) and accordingly high safety (Mamdooh et al, 2019). This foundation furnished for this work basically constructed for elucidation of possible molecular antineoplastic action mechanism via antiinflammation (Hallaq et al, 2022;Khaleel et al, 2022;Qashou et al, 2022;Salih et al, 2022).…”
Section: Statins Repurposing In Chemotherapy Of Cancermentioning
confidence: 74%
See 3 more Smart Citations
“…These data were further validated with other cell lines including colorectal cancer (CRC); fortifying the fact that atorvastatin has an apoptotic effect on cancer cells, particularly colorectal (CRC) and BC (in SW620 cells with IC 50 value accounting to 0.0018 ±0000 µM) and accordingly high safety (Mamdooh et al, 2019). This foundation furnished for this work basically constructed for elucidation of possible molecular antineoplastic action mechanism via antiinflammation (Hallaq et al, 2022;Khaleel et al, 2022;Qashou et al, 2022;Salih et al, 2022).…”
Section: Statins Repurposing In Chemotherapy Of Cancermentioning
confidence: 74%
“…The mechanism of reduction of cell viability was adopted as described previously (Vichai and Kirtikara, 2006). As a robust and classical antineoplastic apoptogenic reference agent (El-Hamoly et al, 2017), cisplatin (1-200 μM) was recruited for comparison purposes (Alabsi et al, 2018;Mamdooh et al, 2019;AlKhalil et al, 2020;Hallaq et al, 2022;Khaleel et al, 2022;Qashou et al, 2022;Salih et al, 2022). Dose-response curves were plotted and values were expressed as percentage of control optical density and IC 50 values 50% inhibitory concentration were estimated by regression analysis (Papazisis et al, 1997).…”
Section: In Vitro Antiproliferation Assaymentioning
confidence: 99%
See 2 more Smart Citations
“…Vosaroxin is a commercial fluoroquinolone (FQ) with antineoplastic propensities in acute myeloid leukemia comparable to anticancer agents doxorubicin and cisplatin (Bruno et al, 2020). Newly developed synthetic chelator Fluoroquinolones (FQs) had the scaffold for FQs but carried extra lipophilic and chelator groups as structural functionalities for optimal cytotoxicities similar to doxorubicin (Arabiyat, et al, 2016a,b;Khaleel et al, 2021;AlHallaq et al, 2022;Qashou et al, 2022). Our hypothesis was based to dual lipophilic-acidic chelating FQs with a genuine potential of antiproliferative propensities based to their dual DPPH-and NO-radicals scavenging biocapacities using cell based -and colorimetric assays vs. respective reference agents as their molecular action mechanism.…”
Section: Research Articlementioning
confidence: 99%